Objective: to analyze the intervention effect and influence value of clinical pharmacists in the prevention of infection during the perioperative period of cesarean section and postpartum birth canal. Methods: the use...Objective: to analyze the intervention effect and influence value of clinical pharmacists in the prevention of infection during the perioperative period of cesarean section and postpartum birth canal. Methods: the use of antibiotics during the perioperative period of cesarean section and postpartum birth canal to prevent infection without the intervention of clinical pharmacists in the obstetrics department of our hospital from January 2018 to December 2018 was taken as the reference stage;The use of antibiotics during the perioperative period of cesarean section and postpartum birth canal after clinical pharmacists' intervention from January 2019 to December 2020 was taken as the observation stage. Select the reference stage, observation stage, obstetrical perioperative and postpartum birth canal to prevent infection of pregnant and parturient women who use antibacterial drugs, and the obstetrical medical staff to carry out this study. Before and after the intervention of clinical pharmacists, the evaluation scores of department management quality, postpartum (premature rupture of membranes, prolonged labor) birth canal infection rate, cesarean section wound infection rate, cure rate of original infectious diseases, perioperative preventive use of antibacterial drugs frequency of use (DDDs), and satisfaction rate of cesarean section pregnant women were compared. Results: compared with the reference stage, the evaluation score of department management quality, the cure rate of original infectious diseases and the satisfaction rate of cesarean section pregnant women in the observation stage were significantly improved (p < 0.05). The infection rates of postpartum (premature rupture of membranes, prolonged labor process), cesarean section wound and perioperative prophylactic use of antibiotics DDDs in the observation stage were significantly lower than those in the reference stage. Conclusion: the effect of clinical pharmacists' intervention and control on the prevention of infection in obstetric perioperative and postpartum birth canal is significant, which can significantly improve the quality of department management, reduce the infection rate in postpartum birth canal (premature rupture of membranes, prolonged labor process), wound infection rate in cesarean section and DDDs for prevention of infection in perioperative and postpartum birth canal, and improve the cure rate of original infectious diseases and the satisfaction rate of pregnant women in cesarean section.展开更多
Background： To prevent adverse drug events and promote patient safety, medication reconciliation is critical in all patient care settings. The purpose of this study was to identify medication discrepancies occurring ...Background： To prevent adverse drug events and promote patient safety, medication reconciliation is critical in all patient care settings. The purpose of this study was to identify medication discrepancies occurring in an inpatient medicine unit and to analyze the clinical and economic benefit of clinical pharmacist and physician team collaboration. Methods： A prospective cohort study in which pharmacist attended daily team rounds and assisted with medication management and medication reconciliation on admission and discharge in an academic hospital with internal medicine residents. All interventions related to medication management were categorized based on error type, severity of harm, preventable, non-preventable and potential adverse drug events. The economic outcome associated with these medication errors was analyzed. Results： There were 160 admissions and 179 pharmacist recommendations with a 91% acceptance rate from physicians. There were 145 discharges during the study period of which 104 medication discrepancies were identified. Eighty nine of the medication discrepancies were corrected by the pharmacist within 72 hours of discharge. Pharmacist identified 11 actual adverse drug events. Cost savings from pharmacist interventions during the study period was $11,652 and cost avoidance from intercepting potential and actual adverse drug events was $256,806. Conclusion： Collaboration of pharmacist with a physician team improved medication safety and led to significant cost savings and cost avoidance.展开更多
The role of pharmacists in the management of neuropsychiatric disorders is an evolving area within healthcare, driven by the need for effective treatment options for mental illnesses affecting over 50 million American...The role of pharmacists in the management of neuropsychiatric disorders is an evolving area within healthcare, driven by the need for effective treatment options for mental illnesses affecting over 50 million Americans. This review examines the critical interventions provided by pharmacists to optimize treatment in neuropsychiatric disorders, emphasizing the multi-faceted nature of their contributions within healthcare teams. Pharmacists’ interventions include medication management, adherence, patient counseling, and other methods that support the prevention of adverse events, and they are key players in enhancing mental health care through collaborative practice models. Objectives: The primary objective of this review is to evaluate the impact of pharmacist-led interventions on patient outcomes in the management of neuropsychiatric disorders, exploring their roles in various settings and collaborative environments. Background: Neuropsychiatric disorders, which span both psychiatric and neurologic conditions, require comprehensive and integrated care approaches. Pharmacists are increasingly involved in medication management, patient education, and adherence strategies essential for managing these disorders effectively. Methods: A literature review was conducted to analyze studies examining pharmacist-led interventions in neuropsychiatric care, including adherence programs, medication reconciliation, adverse event monitoring, and pharmacogenomic applications. Articles were selected based on their focus on pharmacist interventions in community, hospital, and interdisciplinary settings. Results: Evidence suggests that pharmacist-led interventions improve adherence, optimize medication management, and contribute to reducing readmissions in patients with neuropsychiatric disorders. Key findings highlight the success of interventions such as patient counseling, pharmacogenomic-guided therapy, and collaborative care models, demonstrating improved outcomes across various settings. Conclusions: Pharmacists play a critical role in managing neuropsychiatric disorders through comprehensive medication management, patient education, and collaboration with other healthcare providers. Their involvement is essential for safe, effective, and personalized mental health care, underscoring the need to further integrate pharmacists in mental health services.展开更多
The aim of this paper is to detect, prevent and resolve DRP （drug-related problems） and NOM （negative outcomes associated with medication） in hospitalized patients with DM2 （type 2 diabetes） with HTN （hypertens...The aim of this paper is to detect, prevent and resolve DRP （drug-related problems） and NOM （negative outcomes associated with medication） in hospitalized patients with DM2 （type 2 diabetes） with HTN （hypertension） in a tertiary care clinic. Descriptive cross-sectional interventional study is used. DTM （drug therapy monitoring） was conducted in 73 patients using data obtained from clinical histories and interviews. NOM were detected based on symptoms and laboratory test results. The statistical significance was 0.05. It can be found that 23 DRP were detected, primarily in the category ＂likelihood of adverse effects＂ （30.43%） causing NOM in the ＂non-quantitative safety problem＂ category. The NOM detected were related to safety （62%）, effectiveness （24.5%） and necessity （13.5%）. Of the 68.57% of pharmacist interventions accepted, 48.57% were resolved and 20% were not resolved. A simple linear correlation （r = -0.34） analysis indicated a weak association between patient age and severity ofNOM. DTM made it＇possible to detect suspected DRP and NOM, which were then prevented or resolved, improving the control of HTN and DM2 and helping ensure better drug therapy outcomes for patients.展开更多
文摘Objective: to analyze the intervention effect and influence value of clinical pharmacists in the prevention of infection during the perioperative period of cesarean section and postpartum birth canal. Methods: the use of antibiotics during the perioperative period of cesarean section and postpartum birth canal to prevent infection without the intervention of clinical pharmacists in the obstetrics department of our hospital from January 2018 to December 2018 was taken as the reference stage;The use of antibiotics during the perioperative period of cesarean section and postpartum birth canal after clinical pharmacists' intervention from January 2019 to December 2020 was taken as the observation stage. Select the reference stage, observation stage, obstetrical perioperative and postpartum birth canal to prevent infection of pregnant and parturient women who use antibacterial drugs, and the obstetrical medical staff to carry out this study. Before and after the intervention of clinical pharmacists, the evaluation scores of department management quality, postpartum (premature rupture of membranes, prolonged labor) birth canal infection rate, cesarean section wound infection rate, cure rate of original infectious diseases, perioperative preventive use of antibacterial drugs frequency of use (DDDs), and satisfaction rate of cesarean section pregnant women were compared. Results: compared with the reference stage, the evaluation score of department management quality, the cure rate of original infectious diseases and the satisfaction rate of cesarean section pregnant women in the observation stage were significantly improved (p < 0.05). The infection rates of postpartum (premature rupture of membranes, prolonged labor process), cesarean section wound and perioperative prophylactic use of antibiotics DDDs in the observation stage were significantly lower than those in the reference stage. Conclusion: the effect of clinical pharmacists' intervention and control on the prevention of infection in obstetric perioperative and postpartum birth canal is significant, which can significantly improve the quality of department management, reduce the infection rate in postpartum birth canal (premature rupture of membranes, prolonged labor process), wound infection rate in cesarean section and DDDs for prevention of infection in perioperative and postpartum birth canal, and improve the cure rate of original infectious diseases and the satisfaction rate of pregnant women in cesarean section.
文摘Background： To prevent adverse drug events and promote patient safety, medication reconciliation is critical in all patient care settings. The purpose of this study was to identify medication discrepancies occurring in an inpatient medicine unit and to analyze the clinical and economic benefit of clinical pharmacist and physician team collaboration. Methods： A prospective cohort study in which pharmacist attended daily team rounds and assisted with medication management and medication reconciliation on admission and discharge in an academic hospital with internal medicine residents. All interventions related to medication management were categorized based on error type, severity of harm, preventable, non-preventable and potential adverse drug events. The economic outcome associated with these medication errors was analyzed. Results： There were 160 admissions and 179 pharmacist recommendations with a 91% acceptance rate from physicians. There were 145 discharges during the study period of which 104 medication discrepancies were identified. Eighty nine of the medication discrepancies were corrected by the pharmacist within 72 hours of discharge. Pharmacist identified 11 actual adverse drug events. Cost savings from pharmacist interventions during the study period was $11,652 and cost avoidance from intercepting potential and actual adverse drug events was $256,806. Conclusion： Collaboration of pharmacist with a physician team improved medication safety and led to significant cost savings and cost avoidance.
文摘The role of pharmacists in the management of neuropsychiatric disorders is an evolving area within healthcare, driven by the need for effective treatment options for mental illnesses affecting over 50 million Americans. This review examines the critical interventions provided by pharmacists to optimize treatment in neuropsychiatric disorders, emphasizing the multi-faceted nature of their contributions within healthcare teams. Pharmacists’ interventions include medication management, adherence, patient counseling, and other methods that support the prevention of adverse events, and they are key players in enhancing mental health care through collaborative practice models. Objectives: The primary objective of this review is to evaluate the impact of pharmacist-led interventions on patient outcomes in the management of neuropsychiatric disorders, exploring their roles in various settings and collaborative environments. Background: Neuropsychiatric disorders, which span both psychiatric and neurologic conditions, require comprehensive and integrated care approaches. Pharmacists are increasingly involved in medication management, patient education, and adherence strategies essential for managing these disorders effectively. Methods: A literature review was conducted to analyze studies examining pharmacist-led interventions in neuropsychiatric care, including adherence programs, medication reconciliation, adverse event monitoring, and pharmacogenomic applications. Articles were selected based on their focus on pharmacist interventions in community, hospital, and interdisciplinary settings. Results: Evidence suggests that pharmacist-led interventions improve adherence, optimize medication management, and contribute to reducing readmissions in patients with neuropsychiatric disorders. Key findings highlight the success of interventions such as patient counseling, pharmacogenomic-guided therapy, and collaborative care models, demonstrating improved outcomes across various settings. Conclusions: Pharmacists play a critical role in managing neuropsychiatric disorders through comprehensive medication management, patient education, and collaboration with other healthcare providers. Their involvement is essential for safe, effective, and personalized mental health care, underscoring the need to further integrate pharmacists in mental health services.
文摘The aim of this paper is to detect, prevent and resolve DRP （drug-related problems） and NOM （negative outcomes associated with medication） in hospitalized patients with DM2 （type 2 diabetes） with HTN （hypertension） in a tertiary care clinic. Descriptive cross-sectional interventional study is used. DTM （drug therapy monitoring） was conducted in 73 patients using data obtained from clinical histories and interviews. NOM were detected based on symptoms and laboratory test results. The statistical significance was 0.05. It can be found that 23 DRP were detected, primarily in the category ＂likelihood of adverse effects＂ （30.43%） causing NOM in the ＂non-quantitative safety problem＂ category. The NOM detected were related to safety （62%）, effectiveness （24.5%） and necessity （13.5%）. Of the 68.57% of pharmacist interventions accepted, 48.57% were resolved and 20% were not resolved. A simple linear correlation （r = -0.34） analysis indicated a weak association between patient age and severity ofNOM. DTM made it＇possible to detect suspected DRP and NOM, which were then prevented or resolved, improving the control of HTN and DM2 and helping ensure better drug therapy outcomes for patients.
